Educational content from trusted sources. Not a substitute for advice from your doctor or pharmacist.

Medication guide

Tapentadol vs Oxycodone and Hydrocodone

Tapentadol vs oxycodone and hydrocodone: how they differ in side effects, drug interactions, liver safety and US prescription rules.

Information gathered from trusted sources

Updated November 18, 2026

Flat illustration of three different plants in planters on a sunny windowsill, a hand watering one, for a tapentadol vs oxycodone and hydrocodone comparison

Key facts

  • Tapentadol vs oxycodone in one line: both are Schedule II opioid pain medicines that work about equally well for severe pain in clinical trials, but tapentadol tends to cause less nausea and constipation and is processed by the body differently. See our tapentadol (Nucynta) guide for the basics.
  • Hydrocodone is usually sold combined with acetaminophen, which adds a liver-safety limit that tapentadol and plain oxycodone do not have.
  • Oxycodone and hydrocodone are broken down mainly by the liver enzyme CYP3A4, so many common drugs can raise their levels. Tapentadol is mostly cleared by conjugation instead.
  • Tapentadol also blocks norepinephrine reuptake, which brings its own cautions: serotonin syndrome with some antidepressants and a higher seizure risk.
  • All three carry the same FDA boxed warnings for addiction, breathing problems and overdose. None is a “safe” opioid.

If you have been prescribed an opioid after surgery or an injury, or your clinician has suggested switching, you may be weighing tapentadol vs oxycodone or hydrocodone. This plain-language guide explains how the three medicines differ, what head-to-head trials found, and which US safety points matter.

The short answer: for pain relief, the trials show no clear winner. The differences are in side effects, drug interactions, the liver and kidneys, and how each one fits your other health conditions. Those are the questions to raise with your prescriber.

Tapentadol vs oxycodone vs hydrocodone at a glance

The table below summarizes what each drug’s FDA label says. Brand names are examples; generics are widely used for oxycodone and hydrocodone.

Tapentadol (Nucynta, Nucynta ER)Oxycodone (Roxicodone, OxyContin; Percocet with acetaminophen)Hydrocodone (mostly with acetaminophen; Hysingla ER alone)
US scheduleSchedule IISchedule IISchedule II (combination products moved from Schedule III in October 2014)
How it worksOpioid receptor agonist plus norepinephrine reuptake inhibitorOpioid receptor agonistOpioid receptor agonist
Main metabolismMostly conjugation (glucuronidation); CYP enzymes play a minor roleCYP3A4 (and CYP2D6)CYP3A4 (and CYP2D6)
Half-life (immediate release)About 4 hoursAbout 3.5 to 4 hoursAbout 3.8 hours
Extra boxed warningNone beyond the standard opioid warningsCYP3A4 interactionsCYP3A4 interactions; liver injury from acetaminophen in combination products
Distinct cautionsSerotonin syndrome, seizures, no MAOIs within 14 days, avoid in severe liver or kidney impairmentLower starting dose in liver impairmentAcetaminophen limit; avoid other acetaminophen products

Sources: Nucynta label (DailyMed), Roxicodone label (DailyMed), hydrocodone and acetaminophen label (DailyMed).

How they work differently

Oxycodone and hydrocodone are classic opioids. They relieve pain by activating mu-opioid receptors in the brain and spinal cord. That action also causes their main side effects, from constipation to slowed breathing.

Tapentadol activates the same receptor, but less strongly, and it also blocks the reuptake of norepinephrine, a chemical messenger in the body’s own pain-dampening pathways. The idea is that the two actions together give similar pain relief with less opioid “load.” An American Family Physician drug review notes that the clinical relevance of the norepinephrine effect is not fully known. In practice, it is the reason tapentadol is also FDA-approved (as Nucynta ER) for diabetic nerve pain, and the reason it carries extra cautions around antidepressants and seizures.

What happens in the liver

The oxycodone label has a boxed warning that starting a CYP3A4 inhibitor, or stopping a CYP3A4 inducer, can lead to a fatal oxycodone overdose. Examples include some antibiotics, antifungals, HIV medicines and seizure drugs. The hydrocodone label carries the same warning.

The Nucynta label states that metabolism by the cytochrome P450 system “is of less importance” for tapentadol, which is mainly conjugated and has no active metabolites. That can make tapentadol simpler for people on many medicines. It is not interaction-free, though: it still must not be combined with MAOIs, and alcohol, benzodiazepines and other sedatives are dangerous with any opioid.

What head-to-head trials found

Several large randomized trials compared the two directly; almost all were funded by tapentadol’s manufacturer.

The AAFP review adds an important caveat: the gastrointestinal advantage was clearest at lower tapentadol doses, and at higher immediate-release doses nausea rates were similar to oxycodone. Dizziness, sleepiness and headache were comparable between the two. Hydrocodone has not been compared head to head with tapentadol in large trials, so any comparison with hydrocodone relies on each drug’s own label.

Is tapentadol less addictive than oxycodone?

Some US data suggest lower misuse, but not zero. A claims-database study of new users found 65% lower odds of an opioid abuse diagnosis with tapentadol IR than with oxycodone IR over one year (this study was run by the manufacturer’s researchers). Independent national surveillance from the RADARS System found that tapentadol abuse was “low, but present,” and, once adjusted for how often it is prescribed, lower than most but not all Schedule II opioids. The FDA label for every one of these drugs still warns that addiction can occur even at recommended doses.

Hydrocodone and the acetaminophen question

Most hydrocodone prescriptions in the US are combination tablets with acetaminophen (the active ingredient in Tylenol). The hydrocodone and acetaminophen label warns that acetaminophen has been linked to acute liver failure, and that most cases involved more than 4,000 milligrams a day, often from taking more than one acetaminophen product. Check other medicines for “acetaminophen” or “APAP.” Oxycodone also comes with acetaminophen (for example, Percocet), so the same rule applies there. Tapentadol tablets contain no acetaminophen.

Hydrocodone combination products used to be Schedule III. The DEA moved them to Schedule II effective October 6, 2014, so today all three medicines follow the same prescription rules.

Same rules, same core risks

Because tapentadol, oxycodone and hydrocodone are all Schedule II, a prescription cannot be refilled; each fill needs a new written or electronic prescription, as described in the DEA Pharmacist’s Manual. If you are curious about the details, our guide on how to get tapentadol legally in the US walks through the process.

On July 31, 2025, the FDA required updated labeling for all opioid pain medicines, including clearer information on the risks of long-term use, a statement that extended-release opioids should be used only when immediate-release opioids are not enough, and gabapentin and pregabalin added to the list of risky sedating combinations. The CDC 2022 clinical practice guideline also recommends trying nonopioid treatments first for many types of pain. For a fuller look at side effects, see our tapentadol side effects and boxed warnings guide.

Who might be steered toward one or the other

General patterns from the labels, not personal advice:

  • Takes an SSRI, SNRI, tricyclic or triptan: tapentadol needs extra caution because of serotonin syndrome risk (oxycodone and hydrocodone carry this warning too, but tapentadol’s norepinephrine action adds to it).
  • History of seizures: the tapentadol label warns it may increase seizure frequency.
  • Takes many drugs that affect CYP3A4: tapentadol’s metabolism may be easier to manage.
  • Severe kidney or liver disease: tapentadol is not recommended; oxycodone needs a lower starting dose in liver impairment; acetaminophen combinations need care with any liver problem.
  • Insurance and cost: generic oxycodone and hydrocodone are usually covered with fewer hurdles; brand-only tapentadol often needs prior authorization.

Comparing it with a weaker opioid instead? Read tapentadol vs tramadol.

Call 911 right away if someone taking any opioid has slow or shallow breathing, cannot be woken, has blue or gray lips, or has pinpoint pupils. Give naloxone if you have it; the FDA approved naloxone nasal spray for over-the-counter sale in 2023. For a possible overdose or accidental swallowing, you can also call Poison Help at 1-800-222-1222. If you are struggling with opioid use or having thoughts of self-harm, call or text 988.

Questions to ask your prescriber

  • Is an opioid needed for my pain, or are there nonopioid options to try first?
  • Why this opioid rather than the others, given my other medicines and conditions?
  • Do any of my current prescriptions, supplements or antidepressants interact with it?
  • Does my prescription contain acetaminophen, and what else should I avoid?
  • How long should I expect to take it, and what is the plan for stopping?
  • Should I keep naloxone at home?
  • Where can I dispose of leftover tablets? (The FDA’s flush list includes all three when a take-back option is not available.)

Fill prescriptions for these medicines only at a state-licensed US pharmacy; the DEA warns that fake opioid pills sold online often contain fentanyl.

Frequently asked questions

Is tapentadol stronger than oxycodone?

Not in a simple sense. In head-to-head trials, the doses of tapentadol and oxycodone that were studied gave similar pain relief. Tapentadol is less potent at the opioid receptor but adds a second, non-opioid action. Your prescriber chooses the dose for you; never switch or combine opioids on your own.

Does tapentadol cause less constipation than oxycodone?

In manufacturer-funded trials, yes. Constipation, nausea and vomiting were less common with tapentadol than oxycodone, especially at lower tapentadol doses. Constipation can still happen with any opioid, so ask about a bowel plan.

Is hydrocodone safer than tapentadol or oxycodone?

No. Hydrocodone is also a Schedule II opioid with the same boxed warnings. Most hydrocodone products also contain acetaminophen, which adds a risk of liver injury if too much acetaminophen is taken in a day.

Can I take tapentadol if I am on an antidepressant?

Only if your prescriber knows about it and agrees. Tapentadol can cause serotonin syndrome with SSRIs, SNRIs, tricyclics and similar drugs, and it must not be taken with an MAOI or within 14 days of stopping one.

Is tapentadol less addictive than oxycodone?

Some US studies found lower rates of misuse with tapentadol, but the risk is still real. The FDA label for every opioid, including tapentadol, warns that addiction can occur even when the medicine is taken as prescribed.

Related guides

Sources

  1. DailyMed: Nucynta (tapentadol) tablets prescribing information, revised 12/2025
  2. DailyMed: Roxicodone (oxycodone) tablets prescribing information, revised 12/2025
  3. DailyMed: Hydrocodone bitartrate and acetaminophen tablets prescribing information
  4. Erlich DR, Bodine W. Tapentadol (Nucynta) for treatment of pain. American Family Physician, 2012
  5. Hartrick C, et al. Tapentadol IR and oxycodone IR in patients awaiting joint replacement. Clinical Therapeutics, 2009
  6. Buynak R, et al. Tapentadol ER for chronic low back pain. Expert Opinion on Pharmacotherapy, 2010
  7. Wild JE, et al. Long-term safety of tapentadol ER. Pain Practice, 2010
  8. Cepeda MS, et al. Risks of opioid abuse or dependence: tapentadol vs oxycodone. Journal of Pain, 2013
  9. Vosburg SK, et al. Tapentadol abuse liability in the RADARS System. Journal of Pain, 2018
  10. Federal Register: Rescheduling of hydrocodone combination products to Schedule II, August 22, 2014
  11. DEA Diversion Control Division: Pharmacist’s Manual
  12. FDA Drug Safety Communication: opioid labeling changes on long-term use, July 31, 2025
  13. CDC Clinical Practice Guideline for Prescribing Opioids for Pain, 2022
  14. FDA: Information about naloxone and nalmefene
  15. FDA: Drug disposal, FDA’s flush list for certain medicines
  16. DEA: One Pill Can Kill

This guide is for education only

It does not replace advice from your doctor or pharmacist. Never start, stop, or change a medicine on your own. In an emergency call 911; for possible overdose or poisoning call Poison Help at 1-800-222-1222.

Information gathered from trusted sources, including FDA prescribing information, DailyMed, NIH and peer-reviewed research. Sources are cited throughout this guide. Read our editorial policy.